These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6568786

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
    Brown EM.
    J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
    [Abstract] [Full Text] [Related]

  • 4. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W, Hamilton-Miller JM, Dixson S, Gargan RA, Gooding A.
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [Abstract] [Full Text] [Related]

  • 5. Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves.
    Soback S, Bor A, Kurtz B, Paz R, Ziv G.
    J Vet Pharmacol Ther; 1987 Jun; 10(2):105-13. PubMed ID: 3302313
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ, Palmer GH, Buswell JF, Stanton A.
    Vet Rec; 1985 Jan 12; 116(2):33-6. PubMed ID: 3871985
    [Abstract] [Full Text] [Related]

  • 10. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K.
    Jpn J Antibiot; 1985 Aug 12; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract] [Full Text] [Related]

  • 11. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM, Seetulsingh P.
    J Antimicrob Chemother; 1991 Jun 12; 27(6):761-7. PubMed ID: 1669013
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep 12; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y, McGillavry G, Yourassowsky E.
    Acta Clin Belg; 1988 Sep 12; 43(2):109-14. PubMed ID: 3400375
    [No Abstract] [Full Text] [Related]

  • 14. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates.
    Van Landuyt HW, Pyckavet M, Lambert AM.
    J Antimicrob Chemother; 1981 Jan 12; 7(1):65-70. PubMed ID: 6907270
    [No Abstract] [Full Text] [Related]

  • 15. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM, Lamothe F.
    J Antimicrob Chemother; 1986 May 12; 17(5):593-603. PubMed ID: 3636324
    [Abstract] [Full Text] [Related]

  • 16. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1995 Jun 12; 35(6):883-8. PubMed ID: 7559200
    [Abstract] [Full Text] [Related]

  • 17. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
    Semenitz E, Casey PA, Pfaller W, Gstraunthaler G.
    Chemotherapy; 1983 Jun 12; 29(3):192-207. PubMed ID: 6347546
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Pharmaceutical preparation of BRL 25000].
    Jpn J Antibiot; 1985 Feb 12; 38(2):538-41. PubMed ID: 3847526
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.